Advanced search
1 file | 2.00 MB Add to list

A semi-mechanistic population pharmacokinetic/pharmacodynamic model of bortezomib in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 2.00 MB

Citation

Please use this url to cite or link to this publication:

MLA
Janssen, Julie M., et al. “A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.” CLINICAL PHARMACOKINETICS, 2020.
APA
Janssen, J. M., Dorlo, T., Niewerth, D., Wilhelm, A., Zwaan, C., Beijnen, J., … Huitema, A. (2020). A semi-mechanistic population pharmacokinetic/pharmacodynamic model of bortezomib in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. CLINICAL PHARMACOKINETICS.
Chicago author-date
Janssen, Julie M, TPC Dorlo, D Niewerth, AJ Wilhelm, CM Zwaan, JH Beijnen, A Attarbaschi, et al. 2020. “A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.” CLINICAL PHARMACOKINETICS.
Chicago author-date (all authors)
Janssen, Julie M, TPC Dorlo, D Niewerth, AJ Wilhelm, CM Zwaan, JH Beijnen, A Attarbaschi, A Baruchel, F Fagioli, T Klingebiel, Barbara De Moerloose, G Palumbo, A von Stackelberg, GJL Kaspers, and ADR Huitema. 2020. “A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.” CLINICAL PHARMACOKINETICS.
Vancouver
1.
Janssen JM, Dorlo T, Niewerth D, Wilhelm A, Zwaan C, Beijnen J, et al. A semi-mechanistic population pharmacokinetic/pharmacodynamic model of bortezomib in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. CLINICAL PHARMACOKINETICS. 2020;
IEEE
[1]
J. M. Janssen et al., “A semi-mechanistic population pharmacokinetic/pharmacodynamic model of bortezomib in pediatric patients with relapsed/refractory acute lymphoblastic leukemia,” CLINICAL PHARMACOKINETICS, 2020.
@article{8625970,
  author       = {Janssen, Julie M and Dorlo, TPC and Niewerth, D and Wilhelm, AJ and Zwaan, CM and Beijnen, JH and Attarbaschi, A and Baruchel, A and Fagioli, F and Klingebiel, T and De Moerloose, Barbara and Palumbo, G and von Stackelberg, A and Kaspers, GJL and Huitema, ADR},
  issn         = {0312-5963},
  journal      = {CLINICAL PHARMACOKINETICS},
  language     = {eng},
  title        = {A semi-mechanistic population pharmacokinetic/pharmacodynamic model of bortezomib in pediatric patients with relapsed/refractory acute lymphoblastic leukemia},
  url          = {http://dx.doi.org/10.1007/s40262-019-00803-y},
  year         = {2020},
}

Altmetric
View in Altmetric